Using Biologics to Manage Moderate to Severe Atopic Dermatitis

IDEF Educational Series Counseling a Patient with Moderate to Severe Atopic DermatitisПодробнее

Treating moderate-to-severe atopic dermatitis in children and adolescents: Insights from the expertsПодробнее

Updates on Atopic Dermatitis Treatment Options and the Role of BiologicsПодробнее

The Pathogenesis of Inflammatory Dermatologic Disorders and Rationale for Targeted Biologic TherapyПодробнее

Webinar: Applying the Latest Guidelines to Control Moderate-to-Severe Asthma SymptomsПодробнее

Moderate to Severe Atopic Dermatitis: The Role and Clinical Utility of Targeted TherapyПодробнее

Closing the Healthcare Gaps in the Management of Moderate-to-Severe Atopic Dermatitis with BiologicsПодробнее

IDEF Educational Series Webinar: Adbry® Product Theatre: IL 13 and It’s Key Role in Moderate to SevПодробнее

What are Biologics? Can it help treat moderate to severe Atopic Eczema?Подробнее

Psoriatic Disease in Women of Childbearing AgeПодробнее

IDEF: Expanding AD Options for Adults and Pediatric Patients 12 Years of Age and Older With ModerateПодробнее

Reframing the Management Approach for Moderate to Severe Atopic DermatitisПодробнее

Dupixent: The Best Way To Treat Eczema And Atopic DermatitisПодробнее

Atopic Dermatitis (Fonacier)Подробнее

Selecting Targeted Treatment for Patients With Uncontrolled, Moderate to Severe AsthmaПодробнее

New Treatments in Atopic DermatitisПодробнее

Targeted Biologic Therapy for Pediatric and Adult Patients With Moderate to Severe ADПодробнее

Advancing Care for People Living With Moderate to Severe Atopic DermatitisПодробнее

Atopic Dermatitis Livestream 10/13/2020 with Drs. Blaiss and Sublett!Подробнее